KOELIS announces the first interim results of the VIOLETTE trial which evaluates the use of OBT-fusion technology in focal ablation of the prostate by microwave needles

Promising initial results from the VIOLETTE study

The multi-center VIOLETTE study is evaluating the efficacy of focal microwave ablation in patients with localized prostate cancer. The last patient was treated on September 5, 2024 at the Clinique Saint-Augustin in Bordeaux, bringing the total number of patients treated to 76.